Key Stats for P&G Stock
- Current Price: $142.64
- Target Price (Mid): ~$199
- Street Target: ~$161
- Potential Total Return: ~39%
- Annualized IRR: ~7% / year
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
Procter & Gamble (PG) closed fiscal 2026 with organic sales up barely more than 1%, and the stock trades at $142.64, near the low end of its year. On the surface, that is a stalled compounder. Underneath it is a number management cares about far more than the headline: the share of P&G’s largest U.S. customers holding or growing market share climbed from under 10% in the first half of the fiscal year to around 50% in the second. That is the recovery the reported sales line is hiding, and CFO Andre Schulten takes it to the Barclays Global Consumer Staples Conference on September 10.
If the share turn is real, a business the market has written off as flat is quietly re-accelerating, and today’s price is an entry point. If it stalls, P&G is a premium-priced staples name growing 1% while costs rise. The TIKR model leans toward the first reading, with roughly 39% total return to mid-2031 on modest assumptions.
Why Reported Sales Look Worse Than the Business
The cleanest evidence of the disconnect is the gap between what consumers bought and what P&G shipped. In the fourth quarter, U.S. consumption ran at plus 2% while sell-in came in at minus 1%, a three-point gap management attributes to retailer inventory reductions and the shift of Amazon Prime Day out of the quarter. Those are timing distortions and management expects them to wash out over any rolling six-month period.
Greater China grew organic sales 4% and, more tellingly, returned to share growth for the first time in 15 quarters after a long post-COVID slump. Enterprise Markets grew 4%, led by Latin America. On the Q4 call, CEO Shailesh Jejurikar framed the share trend as the leading indicator that matters: “our global share has now stabilized and has been flat for 3-month periods. I think that is a big step forward.”
P&G ran its biggest upgrade in over two decades on original Tide liquid, held the price flat, and improved the product, moving one of its highest-volume franchises from decline to high-single-digit growth. Jejurikar called it “a reward higher than what we had anticipated.” That is the template now being copied across the portfolio: strengthen what already sells rather than lean on promotion. It is slower than a discount blitz, and management chose it on purpose. The $3.8 billion Thorne acquisition announced in August, a premium supplements brand set to close in the fourth quarter, is the other half of the strategy, adding faster-growing wellness exposure, though at roughly $650 million in sales it signals direction more than it moves an $87 billion base.
See historical and forward estimates for P&G stock (It’s free!) >>>
What the Valuation Requires
P&G trades at 20.4 times next-twelve-month earnings, a premium to nearly every household-products peer. Colgate-Palmolive sits at 22.4 times on faster near-term growth, but Kimberly-Clark trades at 13.9 times and Reckitt at 14.3 times, with the peer group median near 14 times. That premium has always rested on franchise quality and a cash return that topped $15 billion in fiscal 2026. The flat year is what puts it under question: if the recovery slips into fiscal 2028, the P/E multiple has room to compress.
Management guided fiscal 2027 to a roughly $1.4 billion after-tax headwind, about $0.56 per share, on a Brent assumption near $90 a barrel, with first-quarter EPS down 5% or more as the worst of it lands early. According to management commentary on the Q4 call, most of that pressure reflects materials produced when oil sat above $100, so it should ease as the year anniversaries.
See how P&G performs against its peers in TIKR (It’s free!) >>>
TIKR Advanced Model Analysis
- Current Price: $142.64
- Target Price (Mid): ~$199, realized by mid-2031
- Potential Total Return: ~39%
- Annualized IRR: ~7% / year
See analysts’ growth forecasts and price targets for P&G stock (It’s free!) >>>
The two revenue drivers are the U.S. share recovery, where the customer-level win rate rose to around 50%, and Enterprise Markets and China, each growing mid-single digits with China back to share growth. Together they support a mid-case revenue CAGR of about 2.5%. The margin driver is productivity, with $2.8 billion of before-tax savings in fiscal 2026 funding reinvestment without gutting earnings. The primary risk is the fiscal 2027 cost wave that front-loads the pain and could delay the re-acceleration.
The upside case is that U.S. innovation converts to visible share gains by the back half of fiscal 2027 and operating margin re-expands, pushing toward the high-case $285. The downside is that oil stays elevated and the recovery slides a year, leaving the stock stalled near the $161 Street mean.
Conclusion
The clock runs to late October, when P&G reports fiscal first quarter. Management has already flagged EPS down 5% or more, so the print itself is not the test. The test is what sits underneath it: whether U.S. consumption and sell-in converge, and whether the top-customer share number holds its climb past 50%. If it does, the recovery is real and the premium is defensible. If organic growth stays stuck below 2%, the premium becomes the problem. Watch the September 10 Barclays tone, then watch October for the proof, with the model implying roughly 7% a year for investors willing to wait through a noisy first half.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in P&G?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up P&G, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track P&G alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
